289 related articles for article (PubMed ID: 26217162)
1. Current knowledge and future research directions in treatment-related second primary malignancies.
Morton LM; Swerdlow AJ; Schaapveld M; Ramadan S; Hodgson DC; Radford J; van Leeuwen FE
EJC Suppl; 2014 Jun; 12(1):5-17. PubMed ID: 26217162
[TBL] [Abstract][Full Text] [Related]
2. Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.
Franklin J; Eichenauer DA; Becker I; Monsef I; Engert A
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD008814. PubMed ID: 28901021
[TBL] [Abstract][Full Text] [Related]
3. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
[TBL] [Abstract][Full Text] [Related]
6. Large Population Analysis of Secondary Cancers in Pediatric Leukemia Survivors.
Yavvari S; Makena Y; Sukhavasi S; Makena MR
Children (Basel); 2019 Nov; 6(12):. PubMed ID: 31795500
[TBL] [Abstract][Full Text] [Related]
7. Polygenic Risk and Chemotherapy-Related Subsequent Malignancies in Childhood Cancer Survivors: A Childhood Cancer Survivor Study and St Jude Lifetime Cohort Study Report.
Im C; Sharafeldin N; Yuan Y; Wang Z; Sapkota Y; Lu Z; Spector LG; Howell RM; Arnold MA; Hudson MM; Ness KK; Robison LL; Bhatia S; Armstrong GT; Neglia JP; Yasui Y; Turcotte LM
J Clin Oncol; 2023 Sep; 41(27):4381-4393. PubMed ID: 37459583
[TBL] [Abstract][Full Text] [Related]
8. Identification of risk factors and prediction models for secondary malignant neoplasms (SMNs)-free survival and SMNs-specific survival in testicular cancer survivors.
Fu H; Talluri S; Rai S; Liang L; Trivedi J; Ankem MK
World J Urol; 2023 Sep; 41(9):2413-2420. PubMed ID: 37530808
[TBL] [Abstract][Full Text] [Related]
9. Second malignant neoplasms and cardiovascular disease following radiotherapy.
Travis LB; Ng AK; Allan JM; Pui CH; Kennedy AR; Xu XG; Purdy JA; Applegate K; Yahalom J; Constine LS; Gilbert ES; Boice JD
J Natl Cancer Inst; 2012 Mar; 104(5):357-70. PubMed ID: 22312134
[TBL] [Abstract][Full Text] [Related]
10. Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.
Groot HJ; Lubberts S; de Wit R; Witjes JA; Kerst JM; de Jong IJ; Groenewegen G; van den Eertwegh AJM; Poortmans PM; Klümpen HJ; van den Berg HA; Smilde TJ; Vanneste BGL; Aarts MJ; Incrocci L; van den Bergh ACM; Jóźwiak K; van den Belt-Dusebout AW; Horenblas S; Gietema JA; van Leeuwen FE; Schaapveld M
J Clin Oncol; 2018 Aug; 36(24):2504-2513. PubMed ID: 29989856
[TBL] [Abstract][Full Text] [Related]
11. Second malignant neoplasms in testicular cancer survivors.
Fung C; Fossa SD; Beard CJ; Travis LB
J Natl Compr Canc Netw; 2012 Apr; 10(4):545-56. PubMed ID: 22491051
[TBL] [Abstract][Full Text] [Related]
12. Secondary Malignancies after Ewing Sarcoma-Epidemiological and Clinical Analysis of an International Trial Registry.
Kaiser I; Kauertz K; Zöllner SK; Hartmann W; Langer T; Jürgens H; Ranft A; Dirksen U
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497401
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. Secondary malignant neoplasms in testicular cancer survivors.
Curreri SA; Fung C; Beard CJ
Urol Oncol; 2015 Sep; 33(9):392-8. PubMed ID: 26072728
[TBL] [Abstract][Full Text] [Related]
15. Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment.
van Leeuwen FE; Ng AK
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):323-330. PubMed ID: 27913498
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors.
Bhatia S
Cancer; 2015 Mar; 121(5):648-63. PubMed ID: 25355167
[TBL] [Abstract][Full Text] [Related]
17. Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.
Kooijmans EC; Bökenkamp A; Tjahjadi NS; Tettero JM; van Dulmen-den Broeder E; van der Pal HJ; Veening MA
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008944. PubMed ID: 30855726
[TBL] [Abstract][Full Text] [Related]
18. Long-term risk of second malignancies in women after breast conservation therapy for ductal carcinoma in situ or early-stage breast cancer.
Kushner CJ; Hwang WT; Wang S; Solin LJ; Vapiwala N
Breast Cancer Res Treat; 2018 Jul; 170(1):45-53. PubMed ID: 29488126
[TBL] [Abstract][Full Text] [Related]
19. Subsequent neoplasms in childhood cancer survivors.
Zichová A; Eckschlager T; Ganevová M; Malinová B; Lukš A; Kruseová J
Cancer Epidemiol; 2020 Oct; 68():101779. PubMed ID: 32682319
[TBL] [Abstract][Full Text] [Related]
20. Risk and prognosis of secondary malignant neoplasms after radiation therapy for bladder cancer: A large population-based cohort study.
Chen R; Zhan X; Jiang H; Liu Y; Jiang Z; Jiang M; Deng W; Liu X; Chen G; Fu B
Front Oncol; 2022; 12():953615. PubMed ID: 36465335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
